| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 67, 18-24, Copyright © 1998 by The American Society for Clinical Nutrition, Inc
REVIEW ARTICLES |
JW Nieves, L Komar, F Cosman and R Lindsay
Clinical Research Center, Helen Hayes Hospital, West Haverstraw, NY 10993, USA. jwn5@columbia.edu
We reviewed published clinical trials that measured bone mass of postmenopausal women from at least one skeletal site to evaluate whether calcium supplementation influenced the efficacy of estrogens and intranasal calcitonin on bone mass change. We compared results of the administration of oral estrogen or nasal calcitonin in conjuction with additional calcium intake either through diet or supplements compared with those of estrogen or calcitonin alone. Of the 31 published estrogen trials analyzed, 20 modified the diet or used a calcium supplement (total 1183 mg/d) and 11 did not (total 563 mg/d). The mean increase in bone mass of the lumbar spine when estrogen was given alone was 1.3%/y (n = 5) compared with 3.3%/y when estrogen was given in conjunction with calcium (n = 14; P = 0.01). The mean increase in bone mass of the femoral neck with estrogen alone (n = 3) was only 0.9%/y compared with 2.4%/y when calcium was given with estrogen (n = 6; P = 0.04). Similarly, forearm bone mass increased 0.4%/y with estrogen alone (n = 7) compared with 2.1%/y when estrogen was given with calcium (n = 12; P = 0.04). Similar results were found when weighted means were calculated. Of the seven published trials evaluating the effects of 200 IU nasal salmon calcitonin, six also used calcium supplements (total 1466 mg/d) whereas one used calcitonin alone (total 627 mg/d). Bone mass of the lumbar spine increased 2.1% with calcitonin plus calcium supplementation compared with -0.2%/y with calcitonin alone. These results suggest that a high calcium intake potentiates the positive effect of estrogen on bone mass at all skeletal sites and perhaps that of calcitonin on bone mass of the spine.
This article has been cited by other articles:
|
|
 |
|
  K. M. McLeod, S. E. McCann, P. J. Horvath, and J. Wactawski-Wende Predictors of Change in Calcium Intake in Postmenopausal Women after Osteoporosis Screening J. Nutr., August 1, 2007; 137(8): 1968 - 1973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. K. Cheong, B. R. Martin, G. S. Jackson, D. Elmore, G. P. McCabe, J. R. Nolan, S. Barnes, M. Peacock, and C. M. Weaver Soy Isoflavones Do Not Affect Bone Resorption in Postmenopausal Women: A Dose-Response Study Using a Novel Approach with 41Ca J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 577 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W Nieves Osteoporosis: the role of micronutrients Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1232S - 1239S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Weaver and J. M. K. Cheong Soy Isoflavones and Bone Health: The Relationship Is Still Unclear J. Nutr., May 1, 2005; 135(5): 1243 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Maurer, M. M. Harris, V. A. Stanford, T. G. Lohman, E. Cussler, S. B. Going, and L. B. Houtkooper Dietary Iron Positively Influences Bone Mineral Density in Postmenopausal Women on Hormone Replacement Therapy J. Nutr., April 1, 2005; 135(4): 863 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Osteoporosis Obstet. Gynecol., October 1, 2004; 104(4_suppl): 66S - 76S. [Full Text] [PDF]
|
|
|
|
|
|
K. L. Becker, E. S. Nylen, J. C. White, B. Muller, and R. H. Snider Jr. Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its Precursors J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1512 - 1525. [Full Text] [PDF]
|
|
|
|
|
|
D. Feskanich, W. C Willett, and G. A Colditz Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women Am. J. Clinical Nutrition, February 1, 2003; 77(2): 504 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mei, S. S. C. Yeung, and A. W. C. Kung High Dietary Phytoestrogen Intake Is Associated with Higher Bone Mineral Density in Postmenopausal but Not Premenopausal Women J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5217 - 5221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Heaney Constructive Interactions among Nutrients and Bone-Active Pharmacologic Agents with Principal Emphasis on Calcium, Phosphorus, Vitamin D and Protein J. Am. Coll. Nutr., October 1, 2001; 20(90005): 403S - 409. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Barrett-Connor and C. A Stuenkel Hormone replacement therapy (HRT)-- risks and benefits Int. J. Epidemiol., June 1, 2001; 30(3): 423 - 426. [Full Text] [PDF]
|
|
|
|
|
|
B. C. Nordin Calcium requirement is a sliding scale Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1381 - 1383. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Heaney Calcium, Dairy Products and Osteoporosis J. Am. Coll. Nutr., April 1, 2000; 19(90002): 83S - 99. [Abstract] [Full Text]
|
|
|
|
|
|
W. W. K. KOO, J. C. WALTERS, J. ESTERLITZ, R. J. LEVINE, A. J. BUSH, and B. SIBAI Maternal Calcium Supplementation and Fetal Bone Mineralization Obstet. Gynecol., October 1, 1999; 94(4): 577 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Bryant, J. Cadogan, and C. M. Weaver The New Dietary Reference Intakes for Calcium: Implications for Osteoporosis J. Am. Coll. Nutr., October 1, 1999; 18(90005): 406S - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Barrett-Connor Fortnightly review: Hormone replacement therapy BMJ, August 15, 1998; 317(7156): 457 - 461. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
